Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94614517 | 9461451 | 7 | F | 2014 | 20160920 | 20130816 | 20160927 | EXP | PHHY2013MX085619 | NOVARTIS | 0.00 | F | Y | 67.00000 | KG | 20160927 | CN | COUNTRY NOT SPECIFIED | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94614517 | 9461451 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 4.6 MG, QD PATCH 5 (CM2) | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 94614517 | 9461451 | 2 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 9.5 MG, QOD PATCH 10 (CM2) | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | |||||||
| 94614517 | 9461451 | 3 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 4.6 MG, QD PATCH 5 (CM2) (OVER 10 YEARS AGO) | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 94614517 | 9461451 | 4 | C | ENALAPRIL | ENALAPRIL | 1 | Unknown | 2 DF, QD | 0 | 2 | DF | QD | |||||||
| 94614517 | 9461451 | 5 | C | RANITIDIN | RANITIDINE HYDROCHLORIDE | 1 | Unknown | 2 DF, QD | 0 | 2 | DF | QD | |||||||
| 94614517 | 9461451 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 94614517 | 9461451 | 7 | C | FLUOXETIN | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 94614517 | 9461451 | 8 | C | SULINDAC. | SULINDAC | 1 | Unknown | 2 DF, QD | 0 | 2 | DF | QD | |||||||
| 94614517 | 9461451 | 9 | C | NAPROXEN. | NAPROXEN | 1 | Unknown | 500 MG, UNK | 0 | 500 | MG | ||||||||
| 94614517 | 9461451 | 10 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Unknown | 2 DF, QD | 0 | 2 | DF | QD | |||||||
| 94614517 | 9461451 | 11 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | 2 MG, UNK | 0 | 2 | MG | ||||||||
| 94614517 | 9461451 | 12 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 94614517 | 9461451 | 13 | C | CALCITRIOL. | CALCITRIOL | 1 | Unknown | 0.25 MG, UNK | 0 | .25 | MG | ||||||||
| 94614517 | 9461451 | 14 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 50 MG, UNK | 0 | 50 | MG | ||||||||
| 94614517 | 9461451 | 15 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 25 MG, UNK | 0 | 25 | MG | ||||||||
| 94614517 | 9461451 | 16 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | Unknown | 0.625 MG, UNK | 0 | .625 | MG | ||||||||
| 94614517 | 9461451 | 17 | C | INDOMETHACIN. | INDOMETHACIN | 1 | Unknown | UNK | 0 | ||||||||||
| 94614517 | 9461451 | 18 | C | MICTASOL | 2 | Unknown | U | 0 | |||||||||||
| 94614517 | 9461451 | 19 | C | CLARITYNE | LORATADINE | 1 | Unknown | U | 0 | ||||||||||
| 94614517 | 9461451 | 20 | C | EAR DROPS RX | 2 | Unknown | U | 0 | EAR DROPS | ||||||||||
| 94614517 | 9461451 | 21 | C | VASCULFLOW | 2 | Unknown | 2 OT, QD | U | 0 | QD | |||||||||
| 94614517 | 9461451 | 22 | C | CHONDROITIN SULFATE | SODIUM CHONDROITIN SULFATE | 1 | Unknown | U | 0 | ||||||||||
| 94614517 | 9461451 | 23 | C | DIACEREIN | DIACEREIN | 1 | Unknown | U | 0 | ||||||||||
| 94614517 | 9461451 | 24 | C | HYPROMELLOSE | HYPROMELLOSES | 1 | Ophthalmic | 3 OT IN EACH EYE DAILY | U | 0 | DROPS | QD | |||||||
| 94614517 | 9461451 | 25 | C | CELECOXIB. | CELECOXIB | 1 | Unknown | 200 MG, UNK | U | 0 | 200 | MG | |||||||
| 94614517 | 9461451 | 26 | C | RISEDRONIC ACID | RISEDRONIC ACID | 1 | Unknown | U | 0 | ||||||||||
| 94614517 | 9461451 | 27 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | U | 0 | ||||||||||
| 94614517 | 9461451 | 28 | C | CALCIUM | CALCIUM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 94614517 | 9461451 | 1 | Dementia Alzheimer's type |
| 94614517 | 9461451 | 2 | Memory impairment |
| 94614517 | 9461451 | 3 | Dizziness |
| 94614517 | 9461451 | 4 | Product used for unknown indication |
| 94614517 | 9461451 | 5 | Product used for unknown indication |
| 94614517 | 9461451 | 6 | Product used for unknown indication |
| 94614517 | 9461451 | 7 | Product used for unknown indication |
| 94614517 | 9461451 | 8 | Product used for unknown indication |
| 94614517 | 9461451 | 9 | Product used for unknown indication |
| 94614517 | 9461451 | 10 | Product used for unknown indication |
| 94614517 | 9461451 | 11 | Product used for unknown indication |
| 94614517 | 9461451 | 12 | Product used for unknown indication |
| 94614517 | 9461451 | 13 | Product used for unknown indication |
| 94614517 | 9461451 | 14 | Product used for unknown indication |
| 94614517 | 9461451 | 15 | Product used for unknown indication |
| 94614517 | 9461451 | 16 | Product used for unknown indication |
| 94614517 | 9461451 | 17 | Product used for unknown indication |
| 94614517 | 9461451 | 18 | Product used for unknown indication |
| 94614517 | 9461451 | 19 | Product used for unknown indication |
| 94614517 | 9461451 | 20 | Product used for unknown indication |
| 94614517 | 9461451 | 21 | Product used for unknown indication |
| 94614517 | 9461451 | 22 | Product used for unknown indication |
| 94614517 | 9461451 | 23 | Product used for unknown indication |
| 94614517 | 9461451 | 24 | Retinal disorder |
| 94614517 | 9461451 | 25 | Product used for unknown indication |
| 94614517 | 9461451 | 26 | Product used for unknown indication |
| 94614517 | 9461451 | 27 | Product used for unknown indication |
| 94614517 | 9461451 | 28 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 94614517 | 9461451 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 94614517 | 9461451 | Cardiac disorder | |
| 94614517 | 9461451 | Concomitant disease aggravated | |
| 94614517 | 9461451 | Deafness | |
| 94614517 | 9461451 | Dizziness | |
| 94614517 | 9461451 | Ear pain | |
| 94614517 | 9461451 | Excoriation | |
| 94614517 | 9461451 | Fall | |
| 94614517 | 9461451 | Feeling abnormal | |
| 94614517 | 9461451 | Gait disturbance | |
| 94614517 | 9461451 | Hallucination | |
| 94614517 | 9461451 | Hallucination, auditory | |
| 94614517 | 9461451 | Head discomfort | |
| 94614517 | 9461451 | Headache | |
| 94614517 | 9461451 | Hypoacusis | |
| 94614517 | 9461451 | Inappropriate schedule of drug administration | |
| 94614517 | 9461451 | Intentional self-injury | |
| 94614517 | 9461451 | Malaise | |
| 94614517 | 9461451 | Mobility decreased | |
| 94614517 | 9461451 | Multiple fractures | |
| 94614517 | 9461451 | Myocardial infarction | |
| 94614517 | 9461451 | Osteoporosis | |
| 94614517 | 9461451 | Product adhesion issue | |
| 94614517 | 9461451 | Product use issue | |
| 94614517 | 9461451 | Retinal detachment | |
| 94614517 | 9461451 | Spinal column injury | |
| 94614517 | 9461451 | Spinal disorder | |
| 94614517 | 9461451 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 94614517 | 9461451 | 1 | 201209 | 2013 | 0 | |
| 94614517 | 9461451 | 4 | 201001 | 0 | ||
| 94614517 | 9461451 | 5 | 201101 | 0 | ||
| 94614517 | 9461451 | 6 | 201001 | 0 | ||
| 94614517 | 9461451 | 7 | 200801 | 0 | ||
| 94614517 | 9461451 | 8 | 201201 | 0 | ||
| 94614517 | 9461451 | 9 | 201201 | 0 | ||
| 94614517 | 9461451 | 10 | 2011 | 0 |